RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Nexien Biopharma - Stock

Nexien Biopharma ROA 2024

Nexien Biopharma ROA

0

Ticker

NXEN

ISIN

US65343D1000

WKN

A2N7Y3

In 2024, Nexien Biopharma's return on assets (ROA) was 0, a -100% increase from the -6 ROA in the previous year.

Nexien Biopharma Aktienanalyse

What does Nexien Biopharma do?

Nexien Biopharma Inc is an American company that focuses on researching and developing therapies for rare diseases. It was founded in 2016 by experienced leaders in the pharmaceutical and biotech industry and is headquartered in Irvine, California. Nexien Biopharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Nexien Biopharma's Return on Assets (ROA)

Nexien Biopharma's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Nexien Biopharma's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Nexien Biopharma's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Nexien Biopharma’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Nexien Biopharma Stock

What is the Return on Assets (ROA) of Nexien Biopharma this year?

The Return on Assets (ROA) of Nexien Biopharma is 0 undefined this year.

What was the ROA of Nexien Biopharma compared to the previous year?

The ROA of Nexien Biopharma has increased by -100% compared to the previous year.

What consequences do high ROA have for investors of Nexien Biopharma?

A high ROA is advantageous for investors of Nexien Biopharma, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Nexien Biopharma?

A low ROA can be unfavorable for investors of Nexien Biopharma as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Nexien Biopharma affect the company?

An increase in ROA of Nexien Biopharma can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Nexien Biopharma impact the company?

A reduction in the ROA of Nexien Biopharma can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Nexien Biopharma?

Some factors that can influence the ROA of Nexien Biopharma include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Nexien Biopharma important for investors?

The ROA of Nexien Biopharma is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Nexien Biopharma take to improve ROA?

To improve ROA, Nexien Biopharma can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Nexien Biopharma pay?

Over the past 12 months, Nexien Biopharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Nexien Biopharma is expected to pay a dividend of 0 USD.

What is the dividend yield of Nexien Biopharma?

The current dividend yield of Nexien Biopharma is .

When does Nexien Biopharma pay dividends?

Nexien Biopharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Nexien Biopharma?

Nexien Biopharma paid dividends every year for the past 0 years.

What is the dividend of Nexien Biopharma?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Nexien Biopharma located?

Nexien Biopharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Nexien Biopharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Nexien Biopharma from 7/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/1/2024.

When did Nexien Biopharma pay the last dividend?

The last dividend was paid out on 7/1/2024.

What was the dividend of Nexien Biopharma in the year 2023?

In the year 2023, Nexien Biopharma distributed 0 USD as dividends.

In which currency does Nexien Biopharma pay out the dividend?

The dividends of Nexien Biopharma are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Nexien Biopharma

Our stock analysis for Nexien Biopharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nexien Biopharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.